Immix Biopharma, Inc. IMMX Accrued Manufacturing Costs
Accrued Manufacturing Costs at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:EmployeeRelatedLiabilitiesCurrent.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s accrued manufacturing costs.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s accrued manufacturing costs?
- Immix Biopharma, Inc. (IMMX) reported accrued manufacturing costs of $880.67K in Q1 2026.
- How has Immix Biopharma, Inc.'s accrued manufacturing costs changed year-over-year?
- Immix Biopharma, Inc.'s accrued manufacturing costs increased by 20.3% year-over-year, from $731.79K to $880.67K.
- What is the long-term trend for Immix Biopharma, Inc.'s accrued manufacturing costs?
- Over 2 years (2023 to 2025), Immix Biopharma, Inc.'s accrued manufacturing costs has grown at a 27.7% compound annual growth rate (CAGR), from $577.85K to $942.16K.